Gefitero 250 Mg Tablets

About Gefitero 250 Mg Tablets

Gefitero 250 mg Tablets contain Gefitinib 250 mg, a targeted anticancer medication primarily used in the treatment of non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking the activity of abnormal proteins that promote cancer cell growth.

Key Features:

• Contains Gefitinib 250 mg per tablet
• Used in the treatment of advanced non-small cell lung cancer
• Helps slow or stop the growth of cancer cells
• Oral administration for convenient dosing
• Manufactured under strict quality standards

Benefits:

• Targets specific cancer cell pathways, reducing damage to normal cells
• Improves disease management in patients with EGFR mutations
• Easy-to-administer tablet form enhances patient compliance

Usage:
Gefitero 250 mg Tablets should be taken orally once daily or as directed by a qualified healthcare professional. Dosage and duration depend on the patients condition and response to treatment.

Packaging:
Available in blister packs or as per buyer requirements.

Storage:
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Safety Information:

• To be used strictly under medical supervision
• Not recommended during pregnancy or breastfeeding
• Patients should inform their doctor about any existing medical conditions